Concentrix director awarded 7,701 RSUs

Marinello Kathryn V reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Marinello Kathryn V reported acquisition or exercise transactions in this Form 4 filing.

Concentrix Corp director Kathryn V. Marinello received an equity grant of 7,701 shares of common stock as restricted stock units. The award was made at no cash price under the 2020 Stock Incentive Plan and vests in full on the earlier of the one-year anniversary of the grant date or the issuer's 2027 Annual Meeting of Stockholders. Following this grant, she directly holds 17,704 shares of Concentrix common stock.

Insider Trade Summary

Grant/Award: 7,701 shares

Grant/Award 1 txn

Insider Marinello Kathryn V

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	7,701	$0.00	$0.00

Holdings After Transaction: Common Stock — 17,704 shares (Direct)

Footnotes (1)

1. F1. Represents shares of restricted stock units awarded under the 2020 Stock Incentive Plan. The restricted stock units vest in full on the earlier of (x) the one-year anniversary of the date of grant and (y) the date of the Issuer's 2027 Annual Meeting of Stockholders.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Concentrix (CNXC) report for Kathryn V. Marinello?

Concentrix reported that director Kathryn V. Marinello acquired 7,701 restricted stock units of common stock as an equity award. The Form 4 shows this as a grant at no cash price under the company’s 2020 Stock Incentive Plan.

How many restricted stock units did the Concentrix (CNXC) director receive?

Kathryn V. Marinello received 7,701 restricted stock units of Concentrix common stock. These units were granted as an equity award and recorded with a per-share transaction price of $0.00, reflecting that they are compensation rather than an open-market purchase.

What is the vesting schedule for Kathryn V. Marinello’s Concentrix (CNXC) RSUs?

The restricted stock units vest in full on the earlier of the one-year anniversary of the grant date or the date of Concentrix’s 2027 Annual Meeting of Stockholders. This creates a single vesting event tied to either time-based or meeting-based milestones.

How many Concentrix (CNXC) shares does Kathryn V. Marinello hold after this grant?

After the grant, Kathryn V. Marinello directly holds 17,704 shares of Concentrix common stock. This total includes the 7,701 restricted stock units reported in the transaction, as shown in the post-transaction ownership figure on the Form 4.

Under which plan were the Concentrix (CNXC) restricted stock units granted?

The 7,701 restricted stock units granted to Kathryn V. Marinello were awarded under Concentrix’s 2020 Stock Incentive Plan. This plan provides for equity-based compensation awards, including restricted stock units, to eligible participants such as directors.

Was Kathryn V. Marinello’s Concentrix (CNXC) equity award a market purchase?

No, the Form 4 classifies the transaction as a grant or award, not a market purchase. The reported per-share transaction price is $0.00, indicating she received the 7,701 restricted stock units as compensation rather than buying them in the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/27/2026 - 08:47 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Marinello Kathryn V

(Last) (First) (Middle)

39899 BALENTINE DRIVE

(Street)

NEWARK CALIFORNIA 94560

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Concentrix Corp [ CNXC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/25/2026		A(1)		7,701	A	$0	17,704	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of restricted stock units awarded under the 2020 Stock Incentive Plan. The restricted stock units vest in full on the earlier of (x) the one-year anniversary of the date of grant and (y) the date of the Issuer's 2027 Annual Meeting of Stockholders.

Remarks:

	/s/ Andrew Farwig, Attorney-in-Fact	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)